🔗 Visit the ClinicalTrials.gov page for NCT01787331
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Molecular pathways and targets in prostate cancer. | Oncotarget | 2014 | 1.00 |
| 2 | Growth factor and signaling pathways and their relevance to prostate cancer therapeutics. | Cancer Metastasis Rev | 2014 | 0.92 |
| 3 | Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. | Cancer Growth Metastasis | 2015 | 0.90 |
| 4 | Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent. | Ecancermedicalscience | 2015 | 0.82 |
| 5 | Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer. | Cancers (Basel) | 2015 | 0.80 |
| 6 | High-dose itraconazole as a noncastrating therapy for a patient with biochemically recurrent prostate cancer. | Clin Genitourin Cancer | 2013 | 0.78 |